Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	16,196	13,216	8,238	7,123	6,832	7,369
Market Cap Growth	-	60.42%	15.65%	4.26%	-7.28%	-17.80%
Enterprise Value	16,569	13,516	8,548	7,394	6,589	6,713
Last Close Price	260.75	213.24	137.67	125.95	122.14	134.54
PS Ratio	16.22	15.64	21.77	24.16	124.47	833.13
PB Ratio	28.79	-69.18	-74.90	-44.23	24.19	7.33
P/TBV Ratio	33.70	-	-	-	26.49	8.39
P/FCF Ratio	315.96	209.00	-	-	-	-
P/OCF Ratio	232.21	209.00	-	-	-	-
EV/Sales Ratio	16.60	16.00	22.59	25.08	120.03	758.93
EV/FCF Ratio	323.24	213.74	-	-	-	-
Debt / Equity Ratio	0.79	-2.37	-3.45	-1.53	1.83	0.11
Debt / EBITDA Ratio	87.54	-	-	-	-	-
Debt / FCF Ratio	14.82	16.18	-	-	-	-
Net Debt / Equity Ratio	0.66	-1.57	-2.81	-1.68	-0.86	-0.65
Net Debt / EBITDA Ratio	31.62	-2.16	-1.14	-0.56	0.42	1.32
Net Debt / FCF Ratio	5.35	4.75	-0.97	-0.52	0.46	1.31
Asset Turnover	0.52	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.10	-0.32	-0.18	0.26	-0.12	-0.09
Quick Ratio	0.68	0.72	0.81	0.62	4.44	7.03
Current Ratio	1.00	1.04	1.17	0.95	5.39	8.03
Return on Equity (ROE)	305.05%	169.84%	300.78%	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	1.30%	-11.77%	-28.17%	-48.30%	-52.15%	-43.72%
Return on Invested Capital (ROIC)	1.39%	-13.90%	-33.32%	-90.87%	-190.06%	-147.02%
Return on Capital Employed (ROCE)	-1.31%	-53.99%	-154.56%	-90.43%	-59.04%	-47.27%
FCF Yield	0.32%	0.48%	-	-	-	-
Buyback Yield / Dilution	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%
Total Shareholder Return	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

SEC Filings: 10-K · 10-Q